Bejar Rafael 4
4 · Aptose Biosciences Inc. · Filed Feb 3, 2020
Insider Transaction Report
Form 4
Bejar Rafael
Chief Medical Officer
Transactions
- Award
Employee Option Grant
2020-01-31+200,000→ 200,000 totalExercise: $6.91Exp: 2030-01-30→ Common Shares (200,000 underlying)
Footnotes (1)
- [F1]Fifty percent (50%) of the options vest on 1/31/2021; the remaining 50% vest as follows: 1/3 on 1/31/2022; 1/3 on 1/31/2023; and 1/3 on 1/31/2024.